Alexander, Veronica J.,Viney, Nicholas J.,Witztum, Joseph L.
申请号：
AU2018211325
公开号：
AU2018211325A1
申请日:
2018.08.03
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018211325A120180830.pdf#####Abstract Provided are methods, compounds, and compositions for reducing expression of Apolipoprotein C-III (ApoCIII) mRNA and protein for treating, preventing, delaying, or ameliorating Familial Chylomicronemia Syndrome (FCS), Lipoprotein lipase deficiency (LPLD) or pancreatitis in an animal with FCS or LPLD.
